• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

European guidelines on cardiovascular prevention in clinical practice were first published in
1994 and have been regularly updated, most recently in 2016, by the Sixth European Joint …

Heart failure is a clinical syndrome that affects> 6.5 million Americans, with an estimated 550
000 new cases diagnosed each year. The complexity of heart failure management is …

Background Approximately 50% of cardiovascular disease (CVD) cases are attributable to
lifestyle risk factors. Despite widespread education, personal knowledge, and efficacy, many …

Digital therapeutics (DTx) is a section of digital health defined by the DTx Alliance as
“delivering evidence-based therapeutic interventions to patients that are driven by software …

The advances in mobile technologies and applications are driving the transformation in
health services delivery globally. Mobile phone penetration is increasing exponentially in …

Background Despite an abundance of digital health interventions (DHIs) targeting the
prevention and management of noncommunicable diseases (NCDs), it is unclear what …

SciELO - Brasil - Guideline of the Brazilian Society of Cardiology on Telemedicine in Cardiology
- 2019 Guideline of the Brazilian Society of Cardiology on Telemedicine in Cardiology - 2019 …